Animal Models Shared Resource Animal models are powerful cancer research tools and a vital link in translating laboratory studies Into the clinic. The function of the Animal Models Shared Resource (AMSR) is to facilitate efficient economical, and state-of-art use of animals for the performance of cancer-related studies. This is accomplished through a centralized resource, where AALAS-certified, highly trained veterinary technicians provide preclinical research services to LCCC members. A significant emphasis is placed on assisting users with the design and performance of animal studies using a wide-range of models, including zebrafish and a recently developed model to study endocrine resistance and breast cancer recurrence in an estrogen receptor positive rat model. Major services provided include all aspects of rodent studies, such as establishing genetically modified mouse colonies, administrating carcinogens, monitoring tumor growth, collecting tissues and tumors at necropsy, and administering drugs, diets or other compounds. Studies using zebrafish include generating gene knockout or gene overexpressing models, screening for toxicity/drugs, and xenotransplantation experiments. Imaging services are also provided to monitor tumor initiation, progression, and response to therapy. The imaging services provided by AMSR include high resolution in vivo small animal imaging and image analysis using a recently upgraded Bruker 7-Tesla magnetic resonance imaging (MRI) and magnetic resonance spectroscopy (MRS) console, a small animal ultrasound (Vevo660) workstation, an X-ray imaging unit (Faxitron) and a visible-near infrared spectroscopic imaging workstation (Maestro II). The AMSR is located within Georgetown University Medical School's Division of Comparative Medicine (DCM). The DCM is a centralized, AAALAC-accredited, USDA-registered animal facility and has an approved letter of assurance on file at the NIH. In 2012, these services were used in support of peer reviewed projects of 18 LCCC members from all four Research Programs. The AMSR is codirected by Leena Hilakavi-Clarke, PhD, and Christopher Albanese, PhD, who oversee the animal and imaging components, respectively

National Institute of Health (NIH)
National Cancer Institute (NCI)
Center Core Grants (P30)
Project #
Application #
Study Section
Subcommittee G - Education (NCI)
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Georgetown University
United States
Zip Code
Bae, Woo Kyun; Yoo, Kyung Hyun; Lee, Ji Shin et al. (2015) The methyltransferase EZH2 is not required for mammary cancer development, although high EZH2 and low H3K27me3 correlate with poor prognosis of ER-positive breast cancers. Mol Carcinog 54:1172-80
Adams, Inez; Christopher, Juleen; Williams, Karen Patricia et al. (2015) What Black Women Know and Want to Know About Counseling and Testing for BRCA1/2. J Cancer Educ 30:344-52
Butrick, Morgan; Kelly, Scott; Peshkin, Beth N et al. (2015) Disparities in uptake of BRCA1/2 genetic testing in a randomized trial of telephone counseling. Genet Med 17:467-75
London, Laricca; Hurtado-de-Mendoza, Alejandra; Song, Minna et al. (2015) Motivators and barriers to Latinas' participation in clinical trials: the role of contextual factors. Contemp Clin Trials 40:74-80
Mays, Darren; Niaura, Raymond S; Evans, W Douglas et al. (2015) Cigarette packaging and health warnings: the impact of plain packaging and message framing on young smokers. Tob Control 24:e87-92
Zhi, Xiuling; Lin, Ling; Yang, Shaoxian et al. (2015) ?II-Spectrin (SPTBN1) suppresses progression of hepatocellular carcinoma and Wnt signaling by regulation of Wnt inhibitor kallistatin. Hepatology 61:598-612
Rush, Christina L; Darling, Margaret; Elliott, Maria Gloria et al. (2015) Engaging Latina cancer survivors, their caregivers, and community partners in a randomized controlled trial: Nueva Vida intervention. Qual Life Res 24:1107-18
Heckler, Mary Mazzotta; Riggins, Rebecca B (2015) ERR? splice variants differentially regulate cell cycle progression. Cell Cycle 14:31-45
Kim, B; Wang, S; Lee, J M et al. (2015) Synthetic lethal screening reveals FGFR as one of the combinatorial targets to overcome resistance to Met-targeted therapy. Oncogene 34:1083-93
Tong, Angie; Kelly, Scott; Nusbaum, Rachel et al. (2015) Intentions for risk-reducing surgery among high-risk women referred for BRCA1/BRCA2 genetic counseling. Psychooncology 24:33-9

Showing the most recent 10 out of 544 publications